YM Biosciences advised that licensees for nimotuzumab evaluating drug in trials

theflyonthewall.com

Fri, Sep 21, 2012, 7:17 AM

YM Biosciences said, "YM has been advised by Daiichi Sankyo Co., Ltd., CIMYM's sub-licensee for nimotuzumab in Japan, that they are evaluating the drug in a Phase II gastric cancer program together with Kuhnil Pharma Co. Ltd., CIMYM's sub-licensee in South Korea, and in a Phase II non-small cell lung cancer program. YM has been advised by Oncoscience AG, CIMYM's sub-licensee for Europe, that they are evaluating nimotuzumab in Phase III glioma and pancreatic cancer programs. YM has been advised by Innogene Kalbiotech PTE Ltd., a CIMYM sub-licensee, that they are evaluating nimotuzumab in Phase II and III head and neck cancer programs and a Phase II cervical cancer program."

Is It Too Late to Buy Taiwan Semiconductor Stock?
The company's shares nearly doubled over the past year, but the rise of AI could create more opportunities ahead.
Motley Fool•1d ago
Tesla stock surges as EV maker will 'accelerate' the launch of cheaper cars
Tesla said it would "accelerate" the launch of new models next year, including lower-cost cars, countering reports earlier this month it had scraped those plans.
Yahoo Finance•2h ago
The IRS says it’s going after wealthy tax cheats. Here’s what new audit stats show.
After Congress approved billions of extra funding for tax compliance, the Internal Revenue Service pledged it would get tougher on rich taxpayers and corporations while avoiding extra scrutiny of middle-class households.
MarketWatch•8h ago
Tesla Earnings Fall To Lowest Since 2021. Tesla Stock Surges Late On 'Affordable' EV.
Tesla earnings tumbled below lowered expectations. Tesla stock jumped late as the EV giant signaled an affordable EV is still it its plans. Elon Musk looms.
Investor's Business Daily•9m ago
JPMorgan’s ‘Bloody Friday’: Why Several Top Financial Advisors Jumped Ship the Same Day
Six teams managing nearly $15 billion in total assets quit JPMorgan Chase’s brokerage unit to join competitors last Friday. Here’s what may have triggered their departures.
Barrons.com•3h ago
I Was Incredibly Wrong About the Tesla Cybertruck
Unit sales appear considerably below my estimates.
Motley Fool•14h ago
California McDonald's Franchise Owner Says, 'The Focus Is On Survival' With 'Unprecedented' $20 Per Hour Minimum Wage Forcing Higher Prices
In response to California's new $20 minimum wage law, fast food franchises are being forced to rethink their business strategies to stay afloat. Scott Rodrick, who owns 18 McDonald's franchises in the state, is considering measures to manage the increased labor costs without resorting to layoffs, which he sees as a last resort. Don't Miss: 82% of Americans aren’t using this government secured 5% passive income stream, are you one of them? The average American couple has saved this much money for
Benzinga•1d ago
Sam Bankman-Fried Agrees to Help FTX Investors Go After Celeb Promoters
Sam Bankman-Fried has inked a settlement agreement with a group of FTX customers who have agreed to drop their class action lawsuit against him in exchange for his help going after celebrity promoters of the collapsed exchange.
CoinDesk•1d ago
Jamie Dimon is worried the US economy is headed back to the 1970s
JPMorgan's CEO is concerned the US economy could be in for a repeat of the stagflation that hampered the country during the 1970s.
Yahoo Finance•4h ago
It's Time to Ditch These 2 "Magnificent Seven" Stocks and Replace Them With 2 Bona Fide Outperformers
Among Microsoft, Apple, Nvidia, Alphabet, Amazon, Meta Platforms, and Tesla, there are two former highfliers that are no longer magnificent.
Motley Fool•2d ago

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

YM Biosciences advised that licensees for nimotuzumab evaluating drug in trials

Recommended Stories

Is It Too Late to Buy Taiwan Semiconductor Stock?

Tesla stock surges as EV maker will 'accelerate' the launch of cheaper cars

The IRS says it’s going after wealthy tax cheats. Here’s what new audit stats show.

Tesla Earnings Fall To Lowest Since 2021. Tesla Stock Surges Late On 'Affordable' EV.

JPMorgan’s ‘Bloody Friday’: Why Several Top Financial Advisors Jumped Ship the Same Day

I Was Incredibly Wrong About the Tesla Cybertruck

California McDonald's Franchise Owner Says, 'The Focus Is On Survival' With 'Unprecedented' $20 Per Hour Minimum Wage Forcing Higher Prices

Sam Bankman-Fried Agrees to Help FTX Investors Go After Celeb Promoters

Jamie Dimon is worried the US economy is headed back to the 1970s

It's Time to Ditch These 2 "Magnificent Seven" Stocks and Replace Them With 2 Bona Fide Outperformers